Clinical Trial Update: N-Terminal Pro-brain Natriuretic Peptide Hormone and Persistent Pulmonary Hypertension

View source ↗

Summary

A clinical trial investigating N-terminal pro-brain natriuretic peptide (NT-proBNP) in persistent pulmonary hypertension of the newborn has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Pulmonary Hypertension of the Newborn

Snippet

Sponsor: Christiana Care Health Services | Conditions: Persistent Pulmonary Hypertension of Newborn | Status: TERMINATED